Sunovion Pharmaceuticals

Home
United States
Marlborough, MA
Sunovion Pharmaceuticals

To view our community guidelines, see here: bit.ly/3CozDLX About Sunovion Pharmaceuticals Inc. https://www.sunovion.com/

Sunovion Pharmaceuticals Inc.

(Sunovion)
Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. The Company has charted new paths to life-transforming treatments that

reflect ongoing investments in research and development and an unwavering commitment to support people with serious psychiatric and neurological conditions. Sunovion’s track record of discovery, development and commercialization of important therapies has included Latuda® (lurasidone HCI), Aptiom® (eslicarbazepine acetate) Lonhala® Magnair® (glycopyrrolate), KYNMOBI® (apomorphine HCI) sublingual film, and others. Web Site Privacy Policy for Facebook: http://www.sunovion.com/util/privacy_facebook.html

Address

84 Waterford Drive
Marlborough, MA
01752

Telephone

(508) 481-6700

Website

http://sunovion.com/

Alerts

Be the first to know and let us send you an email when Sunovion Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Our Story

About Sunovion Pharmaceuticals Inc. (Sunovion) Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological, and respiratory conditions. Sunovion’s track record of discovery, development and commercialization of important therapies has included Brovana® (arformoterol tartrate), Latuda® (lurasidone HCI), Aptiom® (eslicarbazepine acetate) Lonhala® Magnair® (glycopyrrolate), and, most recently, KYNMOBI™ (apomorphine HCI) sublingual film. Find more information at www.sunovion.com and connect on Twitter @Sunovion and LinkedIn.

Our vision is to lead the way to a healthier world. Take On Tomorrow®